Nanosonics Limited (NNCSF)
USD 1.75
(0.0%)
USD 1.75
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 16.01 Million AUD | -45.71% |
| 2023 | 29.5 Million AUD | 285.57% |
| 2022 | 6.51 Million AUD | -49.09% |
| 2021 | 12.8 Million AUD | -17.66% |
| 2020 | 15.55 Million AUD | 0.23% |
| 2019 | 15.51 Million AUD | 272.06% |
| 2018 | 4.17 Million AUD | -68.79% |
| 2017 | 13.36 Million AUD | 1572.47% |
| 2016 | 799 Thousand AUD | 113.5% |
| 2015 | -5.91 Million AUD | -189.67% |
| 2014 | -1.1 Million AUD | 62.21% |
| 2013 | -5.4 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -36.27% |
| 2024 Q4 | 3.66 Million AUD | 0.0% |
| 2024 Q1 | 2.88 Million AUD | -74.8% |
| 2024 Q2 | 7.4 Million AUD | 156.71% |
| 2024 Q3 | 3.66 Million AUD | -50.54% |
| 2023 Q2 | 13.68 Million AUD | 94.1% |
| 2023 Q4 | 11.44 Million AUD | 145.64% |
| 2023 Q1 | 7.05 Million AUD | 319.26% |
| 2023 FY | - AUD | 285.57% |
| 2023 Q3 | 4.66 Million AUD | -65.96% |
| 2022 Q2 | 4.83 Million AUD | 54.34% |
| 2022 Q4 | 1.68 Million AUD | 328.07% |
| 2022 FY | - AUD | -49.09% |
| 2022 Q1 | 3.13 Million AUD | -67.26% |
| 2022 Q3 | -737.5 Thousand AUD | -115.25% |
| 2021 FY | - AUD | -17.66% |
| 2021 Q3 | 4.63 Million AUD | 43.58% |
| 2021 Q4 | 9.57 Million AUD | 106.38% |
| 2021 Q1 | 1.65 Million AUD | -80.84% |
| 2021 Q2 | 3.23 Million AUD | 95.58% |
| 2020 Q4 | 8.62 Million AUD | 138.75% |
| 2020 FY | - AUD | 0.23% |
| 2020 Q1 | 3.8 Million AUD | 40.25% |
| 2020 Q2 | 7.6 Million AUD | 99.92% |
| 2020 Q3 | 3.61 Million AUD | -52.51% |
| 2019 Q4 | 2.71 Million AUD | 0.0% |
| 2019 Q1 | 5.03 Million AUD | 3209.21% |
| 2019 Q2 | 5.03 Million AUD | 0.0% |
| 2019 Q3 | 2.71 Million AUD | -46.09% |
| 2019 FY | - AUD | 272.06% |
| 2018 Q3 | 152 Thousand AUD | -91.96% |
| 2018 FY | - AUD | -68.79% |
| 2018 Q1 | 1.89 Million AUD | -14.0% |
| 2018 Q2 | 1.89 Million AUD | 0.0% |
| 2018 Q4 | 152 Thousand AUD | 0.0% |
| 2017 Q1 | 4.89 Million AUD | 155.35% |
| 2017 Q4 | 2.19 Million AUD | 0.0% |
| 2017 FY | - AUD | 1572.47% |
| 2017 Q3 | 2.19 Million AUD | -55.07% |
| 2017 Q2 | 4.89 Million AUD | 0.0% |
| 2016 Q1 | -1.52 Million AUD | 56.4% |
| 2016 Q4 | 1.91 Million AUD | 0.0% |
| 2016 Q3 | 1.91 Million AUD | 226.08% |
| 2016 Q2 | -1.52 Million AUD | 0.0% |
| 2016 FY | - AUD | 113.5% |
| 2015 Q1 | 528.5 Thousand AUD | -1.12% |
| 2015 FY | - AUD | -189.67% |
| 2015 Q4 | -3.48 Million AUD | 0.0% |
| 2015 Q3 | -3.48 Million AUD | -759.89% |
| 2015 Q2 | 528.5 Thousand AUD | 0.0% |
| 2014 Q2 | -1.55 Million AUD | 0.0% |
| 2014 Q4 | 534.5 Thousand AUD | 0.0% |
| 2014 Q3 | 534.5 Thousand AUD | 134.35% |
| 2014 Q1 | -1.55 Million AUD | -617.8% |
| 2014 FY | - AUD | 62.21% |
| 2013 Q3 | 300.5 Thousand AUD | 110.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q1 | -3 Million AUD | 0.0% |
| 2013 Q2 | -3 Million AUD | 0.0% |
| 2013 Q4 | 300.5 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 1761.698% |
| Ansell Limited | 209.86 Million USD | 92.367% |
| Ansell Limited | 206.3 Million USD | 92.236% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 62.61% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 1085.753% |
| Psykey, Inc. | -1.29 Million USD | 1336.621% |
| ConvaTec Group Plc | 455.5 Million USD | 96.483% |
| ConvaTec Group Plc | 455.5 Million USD | 96.483% |
| Encision Inc. | -544.19 Thousand USD | 3043.43% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 11395.395% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 14671.091% |
| Innovative MedTech Inc. | -7.67 Million USD | 308.736% |
| LifePoint, Inc. | -14.2 Million USD | 212.786% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 358.898% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 5028.615% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 7542.133% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 4047.42% |
| SmileDirectClub, Inc. | -186.13 Million USD | 108.605% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 96.423% |
| SheerVision, Inc. | -110.53 Thousand USD | 14591.862% |
| United Health Products, Inc. | -2.5 Million USD | 740.153% |
| Vasamed, Inc. | -4.57 Million USD | 450.163% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 808.53% |
| Yubo International Biotech Limited | -1.17 Million USD | 1460.125% |